CureDuchenne Ventures
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jun 7, 2022
Code Biotherapeutics
|
Series A | $75M | Biotechnology | — |
Dec 22, 2021
Gennao Bio
|
Series A | $1M | Biotechnology | Yes |
Aug 5, 2021
Pepgen
|
Series Unknown | $112.50M | Biotechnology | — |
Apr 20, 2021
Code Biotherapeutics
|
Seed | $10M | Biotechnology | — |
Mar 31, 2021
Entrada Therapeutics
|
Series B | $116M | Biotechnology | — |
CureDuchenne Ventures has had 7 exits. CureDuchenne Ventures most notable exits include Pepgen , Entrada Therapeutics
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
May 6, 2022 | Pepgen | IPO | Biotechnology | Detail |
Oct 29, 2021 | Entrada Therapeutics | IPO | Biotechnology | Detail |
Mar 26, 2021 | Edgewise Therapeutics | IPO | Biopharma | Detail |
Dec 10, 2020 | 4D Molecular Therapeutics | IPO | Biotechnology | Detail |
Jun 11, 2020 | Avidity Biosciences | IPO | Biotechnology | Detail |